Fluxion Biosciences' Series C Round

Fluxion Biosciences raised a round of funding on December 25, 2009.

Fluxion Biosciences develops cellular analysis tools for use in critical applications in life sciences research and drug discovery. Fluxion's proprietary microfluidic platform, CellFlux, enables preci…

Articles about Fluxion Biosciences' Series C Round: